Arca
Skip to content

CoRegen, Inc.

6 private offerings reported to the SEC on Form D since 2016, $134.3M sold in all. Biotech, TX.

  • Form D offerings: 6
  • Reported sold: $134.3M
  • Newest: Feb 26, 2026

Every Form D Offering

Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
Feb 26, 2026$13.5M$13.5MCoRegen, Inc.Biotech · TXNot amended0002012886-26-000003
May 22, 2025$62.6M$62.6MCoRegen, Inc.Biotech · CONot amended0002012886-25-000003
Feb 28, 2025$20.8M$20.8MCoRegen, Inc.Biotech · CONot amended0002012886-25-000001
Feb 28, 2025$10.0M$10.0MCoRegen, Inc.Biotech · CONot amended0002012886-25-000002
Mar 8, 2024$12.9M$12.9MCoRegen, Inc.Biotech · CONot amended0002012886-24-000002
Feb 22, 2024$14.5MOpen-endedCoRegen, Inc.Biotech · CONot amended0002012886-24-000001

SEC Profile

From the company's EDGAR record
Business address
Houston, Tx
Incorporated in
DE
All SEC filings
CIK 2012886 on EDGAR

A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.